New trial aims to turn back the clock on Pre-Cancerous stomach change

NCT ID NCT06610760

Recruiting now Disease control Sponsor: Yongquan Shi Source: ClinicalTrials.gov ↗

Summary

This study is testing if a medication called ursodeoxycholic acid can reverse a specific change in the stomach lining called intestinal metaplasia, which can increase cancer risk. Researchers will compare the drug to a placebo in about 196 adults who do not have an H. pylori infection. Participants will take the assigned treatment daily for six months and have regular checkups to see if the stomach condition improves or worsens.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

989 Hospital of PLA Joint Logistics Support Force
RECRUITING

Pingdingshan, Henan, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Ankang Central Hospital
RECRUITING

Ankang, Shaanxi, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hanzhong 3201 Hospital
RECRUITING

Hanzhong, Shaanxi, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Shangluo Central Hospital
RECRUITING

Shangluo, Shaanxi, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Xi'an Central Hospital
RECRUITING

Xi'an, Shaanxi, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Xijing hospital
RECRUITING

Xi'an, Shaanxi, 710032, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

GASTRIC INTESTINAL METAPLASIA